ABRACL and breast cancer: For the seven stemness model genes identified in this study, ABRACL has been proposed as a prospective biomarker in endometrial cancer uterine aspirate [27], and Li and Chen [28] reported that ABRACL deletion could suppress proliferation, invasion, migration, and EMT of breast cancer cells.